Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn March

Showing results (41-50 of 268) with videos related to

Pageof 27
Sort By:
Annals of Internal Medicine|April 25, 2009
ACP Journal Club. Students' PEARLS: successfully incorporating evidence-based medicine in medical students' clinical attachmentsMartin R Stockler, Lyn March, Richard I Lindley, et al.
Rheumatology (Oxford, England)|July 2, 2003
Genetic contribution to cartilage volume in women: a classical twin studyDavid J Hunter, Harold Snieder, Lyn March, et al.
Evidence-Based Medicine|August 4, 2009
Students' PEARLS: successfully incorporating evidence-based medicine in medical students' clinical attachmentsMartin R Stockler, Lyn March, Richard I Lindley, et al.
International Journal of Molecular Sciences|October 13, 2021
Skin Barrier Dysregulation in PsoriasisAndreas Orsmond, Lara Bereza-Malcolm, Tom Lynch, et al.
Journal of Clinical Medicine|April 13, 2024
Endothelial Protein C Receptor and Its Impact on Rheumatic DiseaseZachary Daniel O'Hehir, Tom Lynch, Sean O'Neill, et al.
Archives of Internal Medicine|May 11, 2011
Use of PPIs are not associated with mortality in institutionalized older peopleNicholas Wilson, Danijela Gnjidic, Lyn March, et al.
Rheumatology (Oxford, England)|October 9, 2010
Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association DatabaseMargaret P Staples, Lyn March, Marissa Lassere, et al.
BMC Rheumatology|March 20, 2019
Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort studyMargaret P Staples, Lyn March, Catherine Hill, et al.
Cells|March 27, 2026
EPCR in Wound Healing: Mechanisms of Action and Therapeutic PotentialHui Wang, Lyn March, Christopher J Jackson, et al.
BMC Musculoskeletal Disorders|October 21, 2015
Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort studyRachelle Buchbinder, Sharon Van Doornum, Margaret Staples, et al.
Pageof 27

Showing results (41-50 of 268) with videos related to

Sort By:
Pageof 27
Annals of Internal Medicine|April 25, 2009
ACP Journal Club. Students' PEARLS: successfully incorporating evidence-based medicine in medical students' clinical attachmentsMartin R Stockler, Lyn March, Richard I Lindley, et al.
Rheumatology (Oxford, England)|July 2, 2003
Genetic contribution to cartilage volume in women: a classical twin studyDavid J Hunter, Harold Snieder, Lyn March, et al.
Evidence-Based Medicine|August 4, 2009
Students' PEARLS: successfully incorporating evidence-based medicine in medical students' clinical attachmentsMartin R Stockler, Lyn March, Richard I Lindley, et al.
International Journal of Molecular Sciences|October 13, 2021
Skin Barrier Dysregulation in PsoriasisAndreas Orsmond, Lara Bereza-Malcolm, Tom Lynch, et al.
Journal of Clinical Medicine|April 13, 2024
Endothelial Protein C Receptor and Its Impact on Rheumatic DiseaseZachary Daniel O'Hehir, Tom Lynch, Sean O'Neill, et al.
Archives of Internal Medicine|May 11, 2011
Use of PPIs are not associated with mortality in institutionalized older peopleNicholas Wilson, Danijela Gnjidic, Lyn March, et al.
Rheumatology (Oxford, England)|October 9, 2010
Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association DatabaseMargaret P Staples, Lyn March, Marissa Lassere, et al.
BMC Rheumatology|March 20, 2019
Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort studyMargaret P Staples, Lyn March, Catherine Hill, et al.
Cells|March 27, 2026
EPCR in Wound Healing: Mechanisms of Action and Therapeutic PotentialHui Wang, Lyn March, Christopher J Jackson, et al.
BMC Musculoskeletal Disorders|October 21, 2015
Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort studyRachelle Buchbinder, Sharon Van Doornum, Margaret Staples, et al.
Pageof 27